United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News Clover Health launches chronic diseases-focused Clover Therapeutics California-based healthcare company Clover Health has launched a new research subsidiary, called Clover Therapeutics, which will focus on… bypharmanewsdailyJuly 10, 2019
